Permissive Blood Pressure Targets in Pediatric Critical Care: The PRESSURE Randomized Clinical Trial
Adopting a permissive MAP target resulted in no significant difference in risk of death and duration of invasive ventilation at 30 days compared with usual care. Published in JAMA, these peer-reviewed pharmacology findings provide quantitative clinical evidence to inform risk stratification, therapeutic decision-making, and follow-up validation.
Gold-Standard Human Evidence
Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.